Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Giuseppe Ferro is active.

Publication


Featured researches published by Giuseppe Ferro.


Journal of The American Society of Echocardiography | 2012

Application of 2011 American College of Cardiology Foundation/American Society of Echocardiography Appropriateness Use Criteria in Hospitalized Patients Referred for Transthoracic Echocardiography in a Community Setting

Piercarlo Ballo; Fabrizio Bandini; Irene Capecchi; Leandro Chiodi; Giuseppe Ferro; Alberto Fortini; Gabriele Giuliani; Giancarlo Landini; Raffaele Laureano; Massimo Milli; Gabriele Nenci; Francesco Pizzarelli; Giovanni Maria Santoro; Pasquale Vannelli; Carlo Cappelletti; Alfredo Zuppiroli

BACKGROUND A recent American College of Cardiology Foundation and American Society of Echocardiography document updated previous appropriate use criteria (AUC) for echocardiography. The aim of this study was to explore the application of the new AUC, and the resulting appropriateness rate, in hospitalized patients referred for transthoracic echocardiography (TTE) in a community setting. METHODS A total of 931 consecutive inpatients referred for TTE were prospectively recruited in five community hospitals. Patients were categorized as having appropriate, uncertain, or inappropriate indications for TTE according to the AUC. An additional group of 259 inpatients, discharged without having been referred for TTE, was also considered. RESULTS In the group referred for TTE, the large majority of indications (98.8%) were classifiable according to the AUC with good interobserver reproducibility. Indications were appropriate in 739 patients (80.3%), of uncertain appropriateness in 46 (5.0%), and inappropriate in 135 (14.7%). Compared with patients with appropriate or uncertain indications, those with inappropriate indications were younger and more often referred by noncardiologists. Most common causes of inappropriate indications were related to the lack of changes in clinical status or to the absence of cardiovascular symptoms and signs. Examinations with appropriate or uncertain indications had an impact on clinical decision making more often than those with inappropriate indications (86.7% vs 14.1%, P < .0001). In the group discharged without having been referred for TTE, TTE might have been appropriate in 16.2% of cases. CONCLUSIONS Clinical application of the new AUC was highly feasible in a community setting. Although inpatient referral for TTE was appropriate in most patients, strategies aimed at implementing these criteria in clinical practice are desirable.


Nephrology Dialysis Transplantation | 2015

High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study

Vincenzo Panichi; Alessia Scatena; Alberto Rosati; Riccardo Giusti; Giuseppe Ferro; Erasmo Malagnino; Alessandro Capitanini; Adriano Piluso; Paolo Conti; Giada Bernabini; Massimiliano Migliori; David Caiani; Ciro Tetta; Aldo Casani; Giancarlo Betti; Francesco Pizzarelli

BACKGROUND In haemodialysis (HD) patients, anaemia is associated with reduced survival. Despite treatment with erythropoiesis-stimulating agents (ESAs), a large number of patients with chronic kidney disease show resistance to this therapy and require much higher than usual doses of ESAs in order to maintain the recommended haemoglobin (Hb) target, and recent studies suggest that hepcidin (HEP) may mediate the ESA resistance index (ERI). High-volume online haemodiafiltration (HV-OL-HDF) has been shown to improve anaemia and to reduce the need for ESAs in HD patients; this effect is associated with a reduced inflammatory state in these patients. The aim of the REDERT study (role of haemodiafiltration on ERI) was to investigate the effect of different dialysis techniques on ERI and HEP levels in chronic dialysis patients. METHODS A single cross-over, randomized, multicentre study (A-B or B-A) was designed. Forty stable HD patients from seven different dialysis units (male 65%, mean age 67.6 ± 14.7 years and mean dialytic age 48 ± 10 months) were enrolled. Patients were randomized to the standard bicarbonate dialysis (BHD) with low-flux polysulfone (PS) membrane group or to the HV-OL-HDF group with high-flux PS membranes and exchange volume of >20 L/session. After 6 months, patients were shifted to the other dialytic group for a further 6 months. Clinical data, Hb, ESA doses and iron metabolism were recorded every month. HEP, beta2-microglobulin (b2MG) and C-reactive protein (CRP) were determined every 3 months, and ERI was calculated monthly as the weekly ESA dose per kilogram of body weight divided by Hb level. Data were analysed using paired-samples t-test, Wilcoxon signed-rank test and Spearmans correlation coefficient. RESULTS Dialysis efficiency for small molecules assessed as Kt/V was significantly increased in HV-OL-HDF from 1.47 ± 0.24 to 1.49 ± 0.16; P < 0.01. A significant reduction of b2MG was obtained in HV-OL-HDF from month 3 whereas CRP values were not significantly changed during the study period either in BHD or HV-OL-HDF.ERI was significantly reduced in HV-OL-HDF at month 3 and 6 (from 9.1 ± 6.4 UI/weekly/Kg/Hb to 6.7 ± 5.3 UI/weekly/Kg/Hb; P < 0.05) due to a higher ESA consumption in BHD in spite of similar Hb levels. HEP levels were reduced in HV-OL-HDF with respect to BHD after 3 and 6 months. Iron consumption was not significantly different during BHD or HV-OL-HDF treatment as well as transferrin, ferritin and TSAT levels. A significant positive linear correlation between HEP and ERI (r(2) = 0.258, P < 0.001) was observed. CONCLUSIONS In a uraemic patient population with low-grade inflammation treated with HV-OL-HDF, we observed a significant reduction of ERI values as well as HEP levels. The positive correlation between these two parameters supports a role for HEP in the development of ERI in the dialytic population. Moreover, the lower b2MG and the higher Kt/V achieved in HV-OL-HDF confirms the better depurative effect of this technique in comparison with BHD with respect to middle molecules and small-molecular-weight molecules.


Case Reports in Gastroenterology | 2012

Acute Inflammatory Bowel Disease Complicating Chronic Alcoholism and Mimicking Carcinoid Syndrome

Piercarlo Ballo; Pietro Dattolo; Giuseppe Mangialavori; Giuseppe Ferro; Francesca Fusco; Matteo Consalvo; Leandro Chiodi; Francesco Pizzarelli; Alfredo Zuppiroli

We report the case of a woman with a history of chronic alcohol abuse who was hospitalized with diarrhea, severe hypokalemia refractory to potassium infusion, nausea, vomiting, abdominal pain, alternations of high blood pressure with phases of hypotension, irritability and increased urinary 5-hydroxyindoleacetic acid and cortisol. Although carcinoid syndrome was hypothesized, abdominal computed tomography and colonoscopy showed non-specific inflammatory bowel disease with severe colic wall thickening, and multiple colic biopsies confirmed non-specific inflammation with no evidence of carcinoid cells. During the following days diarrhea slowly decreased and the patient’s condition progressively improved. One year after stopping alcohol consumption, the patient was asymptomatic and serum potassium was normal. Chronic alcohol exposure is known to have several deleterious effects on the intestinal mucosa and can favor and sustain local inflammation. Chronic alcohol intake may also be associated with high blood pressure, behavior disorders, abnormalities in blood pressure regulation with episodes of hypotension during hospitalization due to impaired baroreflex sensitivity in the context of an alcohol withdrawal syndrome, increased urinary 5-hydroxyindoleacetic acid as a result of malabsorption syndrome, and increased urinary cortisol as a result of hypothalamic-pituitary-adrenal axis dysregulation. These considerations, together with the regression of symptoms and normalization of potassium levels after stopping alcohol consumption, suggest the intriguing possibility of a alcohol-related acute inflammatory bowel disease mimicking carcinoid syndrome.


European heart journal. Acute cardiovascular care | 2017

Prognostic comparison between creatinine-based glomerular filtration rate formulas for the prediction of 10-year outcome in patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention

Piercarlo Ballo; Tania Chechi; Gaia Spaziani; Veronica Fibbi; Duccio Conti; Giuseppe Ferro; Santi Nigrelli; Pietro Dattolo; Antonio Fazi; Giovanni Maria Santoro; Alfredo Zuppiroli; Francesco Pizzarelli

Background: Estimated glomerular filtration rate (eGFR) is a predictor of outcome among patients with non-ST-elevation acute coronary syndrome (NSTE-ACS), but which estimation formula provides the best long-term risk stratification in this setting is still unclear. We compared the prognostic performance of four creatinine-based formulas for the prediction of 10-year outcome in a NSTE-ACS population treated by percutaneous coronary intervention. Methods: In 222 NSTE-ACS patients submitted to percutaneous coronary intervention, eGFR was calculated using four formulas: Cockcroft–Gault, re-expressed modification of diet in renal disease (MDRD), chronic kidney disease epidemiology collaboration (CKD-Epi), and Mayo-quadratic. Predefined endpoints were all-cause death and a composite of cardiovascular death, non-fatal reinfarction, clinically driven repeat revascularisation, and heart failure hospitalisation. Results: The different eGFR values showed poor agreement, with prevalences of renal dysfunction ranging from 14% to 35%. Over a median follow-up of 10.2 years, eGFR calculated by the CKD-Epi and Mayo-quadratic formulas independently predicted outcome, with an increase in the risk of death and events by up to 17% and 11%, respectively, for each decrement of 10 ml/min/1.73 m2. The Cockcroft–Gault and MDRD equations showed a borderline association with mortality and did not predict events. When compared in terms of goodness of fit, discrimination and calibration, the Mayo-quadratic outperformed the other formulas for the prediction of death and the CKD-Epi showed the best performance for the prediction of events (net reclassification improvement values 0.33–0.35). Conclusions: eGFR is an independent predictor of long-term outcome in patients with NSTE-ACS treated by percutaneous coronary intervention. The Mayo-quadratic and CKD-Epi equations might be superior to classic eGFR formulas for risk stratification in these patients.


Giornale di Tecniche Nefrologiche e Dialitiche | 2013

Acute inflammatory bowel

Pietro Dattolo; Piercarlo Ballo; Stefano Michelassi; Giulia Sansavini; Giuseppe Ferro; Francesca Fusco; Alam Mehmetaj; Giuseppe Mangialavori; Leandro Chiodi; Francesco Pizzarelli

We describe a case of acute inflammatory bowel disease complicating chronic alcoholism and mimicking a carcinoid syndrome, developed in a 65-year-old woman. She was admitted to our hospital because of refractory diarrhea with severe hypokalemia (1.7 mEq/L). Abdominal multi-detector computed tomography, performed before and after intravenous contrast media administration (with double arterial and portal phase), showed diffuse inflammation of the entire colon with severe wall thickening and mural stratification, suggesting a non-specific inflammatory bowel disease. No involvement of the small bowel was found, and there were no findings suggestive of carcinoid tumor or specific inflammatory bowel diseases. Colonoscopy also showed diffuse edema and hyperemia of colic mucosa with no evidence of ulcerative lesions. Multiple colonic biopsies confirmed a non-specific inflammatory bowel disease with no evidence of carcinoid cells. In conclusion, this report suggests that chronic alcohol abuse may lead to acute reversible inflammatory bowel disease, refractory diarrhea and severe hypokalemia, with clinical and laboratory features that can mimic those of a carcinoid syndrome.


Ndt Plus | 2010

Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report

Pietro Dattolo; Stefano Michelassi; Giuseppina Simone; Giuseppe Ferro; Francesco Pizzarelli

Calcimimetics are effective in lowering serum parathyroid hormone (PTH) levels in hyperparathyroidism (HPT). However, they failed to reduce PTH levels in the long term in the setting of primary malignant HPT. A haemodialysis patient suffering from severe longstanding secondary HPT underwent total parathyroidectomy with autotransplantation of parathyroid tissue in her left arm. In the following years, she developed a severe HPT sustained by cancerous transformation of the parathyroid transplanted tissue and resistant both to pharmacological and repeated surgical treatments. The calcimimetic ‘cinacalcet’ was able to effectively reduce serum PTH levels over a 3-year follow-up and to induce disappearance of the neoplastic lesion on radionuclide imaging. Biochemical control of HPT was associated with a remarkable improvement in cardiac function.


Nephrology Dialysis Transplantation | 2006

On-line haemodiafiltration with and without acetate

Francesco Pizzarelli; Tiziano Cerrai; Pietro Dattolo; Giuseppe Ferro


Journal of Nephrology | 2016

Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors

Pietro Dattolo; Pamela Gallo; Stefano Michelassi; Nunzia Paudice; Rossella Cannavò; Elena Romoli; Filippo Fani; Aris Tsalouchos; Alma Mehmetaj; Giuseppe Ferro; Sergio Sisca; Francesco Pizzarelli


Nephrology Dialysis Transplantation | 2017

MP641DRUG COATED BALLOONS REDUCE THE RISK OF RESTENOSIS IN HEMODIALYSIS PATIENTS WITH RECURRENT STENOSIS OF ARTERIOVENOUS FISTULA

Chiara Somma; Giuseppe Ferro; Nunzia Paudice; Nicola Troisi; Pierfrancesco Frosini; Eugenio Romano; Stefano Michelagnoli; Pietro Dattolo


Nephrology Dialysis Transplantation | 2015

FP295RISK FACTORS FOR PROGRESSION TO DIALYSIS AND USE OF ACEI IN CKD STAGE 5

Pamela Gallo; Pietro Dattolo; Elena Romoli; Alma Mehmetaj; Aris Tsalouchos; Stefano Michelassi; Giuseppe Ferro; Francesco Pizzarelli

Collaboration


Dive into the Giuseppe Ferro's collaboration.

Top Co-Authors

Avatar

Francesco Pizzarelli

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Pietro Dattolo

National Research Council

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge